HU1300221A2 - Isitope containing morphine derivatives - Google Patents

Isitope containing morphine derivatives

Info

Publication number
HU1300221A2
HU1300221A2 HU1300221A HU1300221A HU1300221A2 HU 1300221 A2 HU1300221 A2 HU 1300221A2 HU 1300221 A HU1300221 A HU 1300221A HU 1300221 A HU1300221 A HU 1300221A HU 1300221 A2 HU1300221 A2 HU 1300221A2
Authority
HU
Hungary
Prior art keywords
isitope
morphine derivatives
containing morphine
containing
derivatives
Prior art date
Application number
HU1300221A
Inventor
Fueloep Ferenc Dr
Mandity Istvan Dr
Original Assignee
Szegedi Tudomanyegyetem
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Szegedi Tudomanyegyetem filed Critical Szegedi Tudomanyegyetem
Priority to HU1300221A priority Critical patent/HU1300221A2/en
Publication of HU1300221A2 publication Critical patent/HU1300221A2/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
HU1300221A 2013-04-15 2013-04-15 Isitope containing morphine derivatives HU1300221A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HU1300221A HU1300221A2 (en) 2013-04-15 2013-04-15 Isitope containing morphine derivatives

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
HU1300221A HU1300221A2 (en) 2013-04-15 2013-04-15 Isitope containing morphine derivatives
US14/781,116 US9447108B2 (en) 2013-04-15 2014-04-14 Deuterated morphine derivatives
PCT/HU2014/000030 WO2014170704A1 (en) 2013-04-15 2014-04-14 Deuterated morphine derivatives
EP17167947.5A EP3312183A1 (en) 2013-04-15 2014-04-14 Deuterated morphine derivatives
EP14727037.5A EP2986612B1 (en) 2013-04-15 2014-04-14 Deuterated morphine derivatives

Publications (1)

Publication Number Publication Date
HU1300221A2 true HU1300221A2 (en) 2014-10-28

Family

ID=50841884

Family Applications (1)

Application Number Title Priority Date Filing Date
HU1300221A HU1300221A2 (en) 2013-04-15 2013-04-15 Isitope containing morphine derivatives

Country Status (4)

Country Link
US (1) US9447108B2 (en)
EP (2) EP2986612B1 (en)
HU (1) HU1300221A2 (en)
WO (1) WO2014170704A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3077398A1 (en) 2013-12-05 2016-10-12 The University of Bath Novel opioid compounds and their uses
WO2017165738A1 (en) * 2016-03-25 2017-09-28 The Trustees Of Columbia University In The City Of New York Mitragynine alkaloids as opioid receptor modulators
AU2017357755B2 (en) 2016-11-14 2019-06-13 Cindy A. WANG Formulations for the treatment of ocular surface diseases and related methods

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3153042A (en) 1964-10-13 Morphinone and codeinone derivatives
US1980972A (en) 1934-07-19 1934-11-13 Small Lyndon Frederick Morphine derivative and processes for its preparation
US2178010A (en) 1937-02-03 1939-10-31 Small Lyndon Frederick Nuclear substituted derivatives of the morphine series and methods for their preparation
US3254088A (en) 1961-03-14 1966-05-31 Lewenstein Morphine derivative
US3332950A (en) 1963-03-23 1967-07-25 Endo Lab 14-hydroxydihydronormorphinone derivatives
US3814768A (en) 1971-11-26 1974-06-04 Lewenstein E 6-methylene-6-desoxy dihydro morphine and codeine derivatives and pharmaceutically acceptable salts
US5304121A (en) 1990-12-28 1994-04-19 Boston Scientific Corporation Drug delivery system making use of a hydrogel polymer coating
US5716981A (en) 1993-07-19 1998-02-10 Angiogenesis Technologies, Inc. Anti-angiogenic compositions and methods of use
SE9401727D0 (en) 1994-05-18 1994-05-18 Astra Ab In New Compounds
US6099562A (en) 1996-06-13 2000-08-08 Schneider (Usa) Inc. Drug coating with topcoat
DE19939044A1 (en) 1999-08-18 2001-03-15 Gruenenthal Gmbh Use of morphinan derivatives as medicaments
GB9925962D0 (en) 1999-11-02 1999-12-29 Novartis Ag Organic compounds
WO2002089835A2 (en) 2001-05-03 2002-11-14 F. Hoffmann-La Roche Ag Pharmaceutical dosage form of amorphous nelfinavir mesylate
CA2446904A1 (en) 2001-05-24 2003-04-03 Alexza Molecular Delivery Corporation Delivery of drug esters through an inhalation route
US6740641B2 (en) 2001-07-27 2004-05-25 Euro-Celtique, S.A. Sugar derivatives of hydromorphone, dihydromorphine and dihydromorphine, compositions thereof and uses for treating or preventing pain
AU2005292339A1 (en) 2004-09-29 2006-04-13 Cordis Corporation Pharmaceutical dosage forms of stable amorphous rapamycin like compounds
CA2614223A1 (en) * 2005-02-24 2006-08-31 Dr Pharma Nova, Llc A registry method and control system for dea schedule ii-v medicines
EP1813276A1 (en) 2006-01-27 2007-08-01 Euro-Celtique S.A. Tamper resistant dosage forms
EP2051740A4 (en) * 2006-08-16 2010-01-13 Auspex Pharmaceuticals Inc Preparation and utility of opioid analgesics
PL2152709T3 (en) 2007-05-01 2012-07-31 Morphinan compounds
WO2011008636A1 (en) 2009-07-15 2011-01-20 Mallinckrodt Inc. 3-oxy-hydromorphone derivatives
US9768001B2 (en) * 2011-06-06 2017-09-19 Waters Technologies Corporation Compositions, methods, and kits for quantifying target analytes in a sample

Also Published As

Publication number Publication date
US9447108B2 (en) 2016-09-20
EP2986612B1 (en) 2017-06-07
US20160052931A1 (en) 2016-02-25
EP2986612A1 (en) 2016-02-24
WO2014170704A1 (en) 2014-10-23
EP3312183A1 (en) 2018-04-25

Similar Documents

Publication Publication Date Title
GB201311001D0 (en) Lucabella
GB201413149D0 (en) No details
GB201300304D0 (en) Benzylamine derivatives
HK1222846A1 (en) Substituted benzylpyrazoles
NO20160203A1 (en) Stratigraphic function
PL2953956T3 (en) Heteropolyoxometalates
GB201309085D0 (en) Compounds
HK1221717A1 (en) Substituted benzylpyrazoles
GB2533229B (en) Mineral-encapsulated tracers
IL240903D0 (en) Tetrahydropyrrolothiazine compounds
IL241363A (en) Pyridin-4-yl derivatives
GB201304526D0 (en) New compounds
GB201309702D0 (en) Security
IL244609D0 (en) 4-azaindole derivatives
ZA201505790B (en) Amatoxin derivatives
EP2957205A4 (en) Hand-dryer
IL243592D0 (en) Cyanotriazole compounds
GB2514689B (en) Quick-Coupler
PL2994467T3 (en) Arylquinazolines
EP3000028A4 (en) Auto-calendaring
GB201310542D0 (en) Compounds
IL244563D0 (en) Substituted phenylalanine derivatives
SG11201508538SA (en) Complex
ZA201505682B (en) Microanchor
HRP20171948T1 (en) Footlet